Rosa David J. - Feb 6, 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Signature
By: Donna Spinola For: Rosa, David J
Stock symbol
ISRG
Transactions as of
Feb 6, 2023
Transactions value $
-$7,864,761
Form type
4
Date filed
2/7/2023, 03:58 PM
Previous filing
Dec 19, 2022
Next filing
Feb 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ISRG Common Stock Options Exercise $3.42M +54K +46.39% $63.25* 170K Feb 6, 2023 Direct F1
transaction ISRG Common Stock Sale -$11.3M -45K -26.42% $250.53 125K Feb 6, 2023 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISRG Non-Qualified Stock Option (right to buy) Options Exercise $0 -54K -100% $0.00* 0 Feb 6, 2023 Common Stock 54K $63.25 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 15, 2023.
F2 The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $248.78 to $252.47 as follows: 6,434 shares sold at $248.78 to $249.77; 21,711 shares sold at $249.79 to $250.79; 15,580 shares sold at $250.80 to $251.77; and 1,300 shares sold at $251.88 to $252.47. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3 Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 1/8 six months after the date of grant and 1/48th each month thereafter.